Investigation of pharmacokinetic interactions between doravirine and elbasvir-grazoprevir and ledipasvir-sofosbuvir | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Investigation of pharmacokinetic interactions between doravirine and elbasvir-grazoprevir and ledipasvir-sofosbuvir

Ankrom W, Sanchez RI, Yee KL, et al. Investigation of pharmacokinetic interactions between doravirine and elbasvir-grazoprevir and ledipasvir-sofosbuvir. Antimicrob Agents Chemother. 2019;63(5):e02491-18.

Publication Type:

Journal Article

Authors:

Ankrom, W; Sanchez, RI; Yee, KL; et, al

Source:

Antimicrob Agents Chemother, Volume 63, Issue 5, p.e02491-18. (2019)

Cited On:

Patients With HIV/HCV Coinfection

Export Citation:

RIS Format

Top